Gimcheon, South Korea

Juhyeon Bae

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Daegu Gyeongbuk Institute of Science and Technology. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juhyeon Bae: Innovator in Gene Expression Modulation

Introduction

Juhyeon Bae is a notable inventor based in Gimcheon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the modulation of gene expression. His innovative work has led to the development of a unique patent that addresses important biological processes.

Latest Patents

Juhyeon Bae holds a patent titled "Composition comprising farnesol and use thereof." This patent describes a method of increasing PGC-1α gene expression, decreasing PARIS gene expression, or promoting farnesylation of PARIS in a mammalian cell. The method involves administering an effective amount of farnesol, a pharmaceutically acceptable salt thereof, or a solvate thereof to the cell. This invention has potential applications in therapeutic strategies targeting gene expression.

Career Highlights

Juhyeon Bae is affiliated with the Daegu Gyeongbuk Institute of Science and Technology, where he conducts research and development in the field of biotechnology. His work focuses on innovative solutions that can impact health and medicine. With 1 patent to his name, he has established himself as a promising inventor in his field.

Collaborations

Juhyeon Bae collaborates with esteemed colleagues such as Sungchun Cho and Kyungho Kim. Their combined expertise enhances the research output and innovation at their institute.

Conclusion

Juhyeon Bae's contributions to gene expression modulation through his patent demonstrate his commitment to advancing biotechnology. His work has the potential to influence future therapeutic approaches and improve health outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…